Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Davide Fiore Bavaro, Deborah Fiordelisi, Gioacchino Angarano, Laura Monno & Annalisa Saracino. (2020) Targeted therapies for autoimmune/idiopathic nonmalignant diseases: risk and management of opportunistic infections. Expert Opinion on Drug Safety 19:7, pages 817-842.
Read now
Read now
HB Tenstad, K Mose & A Voss. (2020) Herpes zoster infection-induced common peroneal nerve paresis resulting in foot drop in a patient with eosinophilic fasciitis: a case report. Scandinavian Journal of Rheumatology 49:3, pages 251-252.
Read now
Read now
Federica Brosio, Giulia Masetti, Giulio Matteo, Armando Stefanati & Giovanni Gabutti. (2018) A novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profile. Infection and Drug Resistance 11, pages 1401-1411.
Read now
Read now
Ivan Noreña, Mario Fernández-Ruiz & José María Aguado. (2018) Viral infections in the biologic therapy era. Expert Review of Anti-infective Therapy 16:10, pages 781-791.
Read now
Read now
Charlotte Warren-Gash, Harriet Forbes & Judith Breuer. (2017) Varicella and herpes zoster vaccine development: lessons learned. Expert Review of Vaccines 16:12, pages 1191-1201.
Read now
Read now
Articles from other publishers (20)
Joanna Schaenman & Robin Avery. (2023) Cowpox to COVID: History of vaccination in the immunocompromised host. Transplant Infectious Disease 25:3.
Crossref
Crossref
Andre Avelino Costa Beber, Ana Maria Benvegnú, Daniela da Pieve, Lia Natália Diehl Dallazem & Luis Felipe Teixeira Neumaier. 2023. Dermatology in Public Health Environments. Dermatology in Public Health Environments
203
291
.
Jennifer L. Spencer Clinton, Tabitha E. Hoornweg, Jie Tan, Rongsheng Peng, Willem Schaftenaar, Victor P.M.G. Rutten, Cornelis A.M. de Haan & Paul D. Ling. (2022) EEHV1A glycoprotein B subunit vaccine elicits humoral and cell-mediated immune responses in mice. Vaccine 40:35, pages 5131-5140.
Crossref
Crossref
Hyo Jung Nam, Sung Jun Hong, Ara Lee, Jiyeon Kim, Sangho Lee, Corey Casper, Darrick Carter, Steven G. Reed, George Simeon & Eui-Cheol Shin. (2022) An adjuvanted zoster vaccine elicits potent cellular immune responses in mice without QS21. npj Vaccines 7:1.
Crossref
Crossref
Taylor Pursell, Jennifer L. Spencer Clinton, Jie Tan, Rongsheng Peng & Paul D. Ling. (2022) Modified vaccinia Ankara expressing EEHV1A glycoprotein B elicits humoral and cell-mediated immune responses in mice. PLOS ONE 17:3, pages e0265424.
Crossref
Crossref
Anne A Gershon & Michael D Gershon. (2022) Widespread Use of Varicella Vaccine Does Not Reduce Immunity to Zoster of Others. The Journal of Infectious Diseases 225:3, pages 361-363.
Crossref
Crossref
Desmond Curran, Joon H. Kim, Sean Matthews, Christophe Dessart, Myron J. Levin, Lidia Oostvogels, Megan E. Riley, Kenneth E. Schmader, Anthony L. Cunningham, Shelly A. McNeil, Anne E. Schuind & Melissa K. Andrew. (2020) Recombinant Zoster Vaccine Is Efficacious and Safe in Frail Individuals. Journal of the American Geriatrics Society 69:3, pages 744-752.
Crossref
Crossref
Ariane de Jesus Lopes de Abreu, Amanda Venys, Wilson Jacob, Thiago da Silva, Angela Henrique, Kusuma Gopala & Eliana Nogueira Castro de Barros. (2021) Burden of herpes zoster among Brazilian adults – a hospital-based study. Geriatrics Gerontology and Aging 15.
Crossref
Crossref
Vana Spoulou, Johannes Liese & Timo Vesikari. 2021. Pediatric Vaccines and Vaccinations. Pediatric Vaccines and Vaccinations
91
99
.
Benjamin E. Warner, William F. Goins, Phillip R. Kramer & Paul R. Kinchington. 2023. Varicella-zoster Virus. Varicella-zoster Virus
189
221
.
J. Gaillat. (2020) Zona. Revue des Maladies Respiratoires Actualités 12, pages A17-A20.
Crossref
Crossref
Linn Persson Berg, Elisabeth Thomsson, Gentiana Hasi, Malin Bäckström & Tomas Bergström. (2020) Recombinant Epstein-Barr virus glycoprotein 350 as a serological antigen. Journal of Virological Methods 284, pages 113927.
Crossref
Crossref
Étienne Racine, Vladimir Gilca, Rachid Amini, Matthew Tunis, Shainoor Ismail & Chantal Sauvageau. (2020) A systematic literature review of the recombinant subunit herpes zoster vaccine use in immunocompromised 18–49 year old patients. Vaccine 38:40, pages 6205-6214.
Crossref
Crossref
Jialing Lin, James G. Wood, Carla Bernardo, Nigel P. Stocks & Bette Liu. (2020) Herpes zoster vaccine coverage in Australia before and after introduction of a national vaccination program. Vaccine 38:20, pages 3646-3652.
Crossref
Crossref
Shinichi Imafuku, Giulia Dormal, Yasushi Goto, Céline Jégou, Dominique Rosillon & Taizo Matsuki. (2020) Risk of herpes zoster in the Japanese population with immunocompromising and chronic disease conditions: Results from a claims database cohort study, from 2005 to 2014. The Journal of Dermatology 47:3, pages 236-244.
Crossref
Crossref
Jennifer A. Whitaker, Kenneth Valles, Pritish K. Tosh & Gregory A. Poland. 2019. Vaccinations. Vaccinations
139
162
.
Lei Wang, Erik A. M. Verschuuren, Coretta C. van Leer-Buter, Stephan J. L. Bakker, Anoek A. E. de Joode, Johanna Westra & Nicolaas A. Bos. (2018) Herpes Zoster and Immunogenicity and Safety of Zoster Vaccines in Transplant Patients: A Narrative Review of the Literature. Frontiers in Immunology 9.
Crossref
Crossref
Anthony L Cunningham, Thomas C Heineman, Himal Lal, Olivier Godeaux, Roman Chlibek, Shinn-Jang Hwang, Janet E McElhaney, Timo Vesikari, Charles Andrews, Won Suk Choi, Meral Esen, Hideyuki Ikematsu, Martina Kovac Choma, Karlis Pauksens, Stéphanie Ravault, Bruno Salaun, Tino F Schwarz, Jan Smetana, Carline Vanden Abeele, Peter Van den Steen, Ilse Vastiau, Lily Yin Weckx & Myron J Levin. (2018) Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older. The Journal of Infectious Diseases 217:11, pages 1750-1760.
Crossref
Crossref
Marieke van der Heiden, Lia G. H. de Rond, Menno C. van Zelm, Guy A. M. Berbers, Annemieke M. H. Boots & Anne-Marie Buisman. (2018) Age-Dependent Pre-Vaccination Immunity Affects the Immunogenicity of Varicella Zoster Vaccination in Middle-aged Adults. Frontiers in Immunology 9.
Crossref
Crossref
Michael N Oxman, Ruth Harbecke & David M Koelle. (2017) Clinical Usage of the Adjuvanted Herpes Zoster Subunit Vaccine (HZ/su): Revaccination of Recipients of Live Attenuated Zoster Vaccine and Coadministration With a Seasonal Influenza Vaccine. The Journal of Infectious Diseases 216:11, pages 1329-1333.
Crossref
Crossref